Abstract

HDL is the primary mediator of cholesterol mobilization from the periphery to the liver via reverse cholesterol transport (RCT). A critical first step in this process is the uptake of cholesterol from lipid-loaded macrophages by HDL, a function of HDL inversely associated with prevalent and incident cardiovascular disease. We hypothesized that the dynamic ability of HDL to undergo remodeling and exchange of apoA-I is an important and potentially rate-limiting aspect of RCT. In this study, we investigated the relationship between HDL-apoA-I exchange (HAE) and serum HDL cholesterol (HDL-C) efflux capacity. We compared HAE to the total and ABCA1-specific cholesterol efflux capacity of 77 subjects. We found that HAE was highly correlated with both total (r = 0.69, P < 0.0001) and ABCA1-specific (r = 0.47, P < 0.0001) efflux, and this relationship remained significant after adjustment for HDL-C or apoA-I. Multivariate models of sterol efflux capacity indicated that HAE accounted for approximately 25% of the model variance for both total and ABCA1-specific efflux. We conclude that the ability of HDL to exchange apoA-I and remodel, as measured by HAE, is a significant contributor to serum HDL efflux capacity, independent of HDL-C and apoA-I, indicating that HDL dynamics are an important factor in cholesterol efflux capacity and likely RCT.

Highlights

  • HDL is the primary mediator of cholesterol mobilization from the periphery to the liver via reverse cholesterol transport (RCT)

  • We investigated the relationship between HDL dynamics and cholesterol efflux capacity in human subjects

  • Our previous work indicated that the ability of HDL to remodel and/or exchange apoA-I is attenuated in CVD subjects with similar apoA-I and HDL cholesterol (HDL-C) levels, suggesting that direct measurement of HDL dynamics measures a HDL property distinct from apoA-I or cholesterol concentration [31]

Read more

Summary

Introduction

HDL is the primary mediator of cholesterol mobilization from the periphery to the liver via reverse cholesterol transport (RCT). We investigated the relationship between HDL-apoA-I exchange (HAE) and serum HDL cholesterol (HDL-C) efflux capacity. The causal relationship between HDL-C level and reduced CVD risk has been questioned in light of human genetic variations that reduce HDL-C yet do not increase CVD risk, such as LCAT deficiency and apoA-IMilano [8, 9], and clinical studies of compounds that increase HDL-C but do not improve cardiovascular outcomes [10,11,12] These observations underscore the complexities of HDL and the importance of direct measurement of HDL function (biological activity), in particular, its ability to facilitate RCT. ApoA-I, the major protein component of HDL, plays a key role in RCT, and is integral to the interaction between HDL and the various receptors and HDL remodeling

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.